These trials are effectively phase-2’s in size and scope; I think Boehringer Ingelheim has designated them as phase-1’s because, as a private company, it is incentivized to play down the progress of the program.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.